INVA
Closed
Innoviva Inc
19.79
-0.30 (-1.49%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 20.09
Day's Range: 19.76 - 20.185
Send
sign up or login to leave a comment!
When Written:
11.34
Innoviva Inc is a publicly-traded biopharmaceutical company headquartered in Brisbane, California. The company was founded in 1996 as Theravance, Inc. and changed its name to Innoviva, Inc. in 2016. Innoviva is focused on developing and commercializing innovative therapies for respiratory diseases, such as chronic obstructive pulmonary disease (COPD) and asthma.
The company has a strategic collaboration with GlaxoSmithKline (GSK) for the development and commercialization of certain respiratory products, including the long-acting beta2 agonist (LABA) medicines Anoro Ellipta and Breo Ellipta. Innoviva receives royalties on sales of these products, which have been approved in multiple countries.
In addition to its collaboration with GSK, Innoviva is also developing its own pipeline of respiratory therapies. The company's lead product candidate is a once-daily, long-acting muscarinic antagonist (LAMA) for the treatment of COPD.
As of 2021, Innoviva has a market capitalization of approximately $1 billion and employs over 60 people.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
The company has a strategic collaboration with GlaxoSmithKline (GSK) for the development and commercialization of certain respiratory products, including the long-acting beta2 agonist (LABA) medicines Anoro Ellipta and Breo Ellipta. Innoviva receives royalties on sales of these products, which have been approved in multiple countries.
In addition to its collaboration with GSK, Innoviva is also developing its own pipeline of respiratory therapies. The company's lead product candidate is a once-daily, long-acting muscarinic antagonist (LAMA) for the treatment of COPD.
As of 2021, Innoviva has a market capitalization of approximately $1 billion and employs over 60 people.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!